These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19026523)

  • 21. [Effect of microparticles on echinocandin B production by Aspergillus nidulans].
    Niu K; Hu Y; Mao J; Zou S; Zheng Y
    Sheng Wu Gong Cheng Xue Bao; 2015 Jul; 31(7):1082-8. PubMed ID: 26647583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of novel cell wall destabilizing antifungal compounds using a conditional Aspergillus nidulans protein kinase C mutant.
    Mircus G; Hagag S; Levdansky E; Sharon H; Shadkchan Y; Shalit I; Osherov N
    J Antimicrob Chemother; 2009 Oct; 64(4):755-63. PubMed ID: 19648579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
    Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskou A; Ramani R
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):365-8. PubMed ID: 22726528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proposed quality control ranges for 2-microg anidulafungin disk diffusion testing and ability of the method to detect strains with elevated echinocandin MIC values.
    Jones RN; Ross JE; Sheehan DJ
    Diagn Microbiol Infect Dis; 2008 Dec; 62(4):474-7. PubMed ID: 18990524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anidulafungin: a new echinocandin with a novel profile.
    Vazquez JA
    Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspergillus nidulans cell wall composition and function change in response to hosting several Aspergillus fumigatus UDP-galactopyranose mutase activity mutants.
    Alam MK; van Straaten KE; Sanders DA; Kaminskyj SG
    PLoS One; 2014; 9(1):e85735. PubMed ID: 24454924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between naturally occurring antifungal agents.
    Tóth V; Szilágyi M; Anton F; Leiter E; Pócsi I; Emri T
    Acta Biol Hung; 2013 Dec; 64(4):510-2. PubMed ID: 24275596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Activity of itraconazole against clinical isolates of Aspergillus spp. and Fusarium spp. determined by the M38-P NCCLS method].
    Carrillo-Muñoz AJ; Quindós G; Ruesga M; Brió S; del Valle O; Rodríguez V; Hernández-Molina JM; Cantón E; Pemán J; Santos P
    Rev Esp Quimioter; 2001 Sep; 14(3):281-5. PubMed ID: 11753450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sphingolipids mediate differential echinocandin susceptibility in Candida albicans and Aspergillus nidulans.
    Healey KR; Challa KK; Edlind TD; Katiyar SK
    Antimicrob Agents Chemother; 2015; 59(6):3377-84. PubMed ID: 25824222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unnatural tetradeoxy echinocandins produced by gene cluster design and heterologous expression.
    Yu X; Jiang Q; Chen X; Shu H; Xu Y; Sheng H; Yu Y; Wang W; Keller NP; Xu J; Wang P
    Org Biomol Chem; 2023 May; 21(17):3552-3556. PubMed ID: 36807630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anidulafungin: when and how? The clinician's view.
    George J; Reboli AC
    Mycoses; 2012 Jan; 55(1):36-44. PubMed ID: 21668526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility of Aspergillus spp. clinical isolates to albendazole.
    Berthet N; Faure O; Bakri A; Ambroise-Thomas P; Grillot R; Brugère JF
    J Antimicrob Chemother; 2003 Jun; 51(6):1419-22. PubMed ID: 12716778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of CLSI broth macrodilution and microdilution methods for echinocandin susceptibility testing of 5 Candida species.
    Bopp LH; Baltch AL; Ritz WJ; Smith RP
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):320-2. PubMed ID: 21937187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anidulafungin: a novel echinocandin.
    Vazquez JA; Sobel JD
    Clin Infect Dis; 2006 Jul; 43(2):215-22. PubMed ID: 16779750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using Aspergillus nidulans to identify antifungal drug resistance mutations.
    He X; Li S; Kaminskyj SG
    Eukaryot Cell; 2014 Feb; 13(2):288-94. PubMed ID: 24363365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.
    Lewis RE; Kontoyiannis DP
    J Antimicrob Chemother; 2005 Nov; 56(5):887-92. PubMed ID: 16188916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspergillus nidulans is frequently resistant to amphotericin B.
    Kontoyiannis DP; Lewis RE; May GS; Osherov N; Rinaldi MG
    Mycoses; 2002 Nov; 45(9-10):406-7. PubMed ID: 12421291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anidulafungin--state of affairs from a clinical perspective.
    Vehreschild JJ; Kümmerle T; Karthaus M; Cornely OA
    Mycoses; 2007; 50 Suppl 1():38-43. PubMed ID: 17394608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparative separation of echinocandin B from Aspergillus nidulans broth using macroporous resin adsorption chromatography.
    Zou SP; Liu M; Wang QL; Xiong Y; Niu K; Zheng YG; Shen YC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 978-979():111-7. PubMed ID: 25541471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.